Evaluating the Medication Adherence From the Viewpoints of Patients With Mental Disorders and Their Families

authors:

avatar Reza Zeighami 1 , avatar Seyed Mohsen Zamir 2 , avatar Amir Javadi ORCID 3 , avatar Tahereh Mahmoudi 1 , *

Department of Psychiatric Nursing, School of Nursing and Midwifery, Qazvin University of Medical Sciences, Qazvin, Iran.
Department of Psychiatry, School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.
Department of Social Medicine, School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.
Journal of Inflammatory Diseases: Vol.24, issue 1; 44-55
article type: issue_documents_importer

How To Cite Zeighami R, Zamir S M , Javadi A, Mahmoudi T. Evaluating the Medication Adherence From the Viewpoints of Patients With Mental Disorders and Their Families. J Inflamm Dis. 2020;24(1):e156200. 

Abstract

Background: Medication non-adherence is common among patients with mental disorders. It can lead to worsening symptoms, recurrence, re-hospitalization, decreased performance, and increased risk of death. Objective: This study aimed to evaluate the medication adherence from the viewpoints of family and patients with mental disorders. Methods: In this descriptive-analytical study, 102 patients with mental disorders admitted to psychiatric wards of 22 Bahman Hospital in Qazvin province and 102 of their family members were selected using by a convenience sampling method in 2017. In order to collect data, a demographic form and Morisky Medication Adherence Scale (MMAS) were completed by the patients and one of their family members. Data were analyzed in SPSS V. 24 software. Findings: The mean MMAS score of patients was 5.8±1.52 and for their families, it was 5.9±1.46 (in a range of 2-8). Using the Spearman correlation coefficient, results showed a significant and positive correlation between the MMAS scores of patients and their families. Conclusion: Demographic characteristics of patients affect their medication adherence regardless of the type and severity of their disease. Therefore, the role of the patient as an active decision-maker in treatment should be considered. Training and useful advices from medical staff are essential to raise the awareness of the patients and their families about medications and their effectiveness as well as the condition caused by the disease.

References

  • 1.

    Sadock BJ, Sadock VA. Kaplan and Sadocks synopsis of psychiatry: Behavioral sciences/clinical psychiatry. Philadelphia: Lippincott Williams & Wilkins; 2011. https://books.google.com/ books?id=fFi7DR2hmaIC&dq.

  • 2.

    Manjunatha N, Singh G. Manochaitanya: Integrating mental health into primary health care. Lancet. 2016; 387(10019):6478.[DOI:10.1016/S0140-6736(16)00286-5] [PMID].

  • 3.

    Sarrami H, Ghorbani M, Minooei M. Survey of four decades of addiction prevalence researches in Iran. J Res Addict. 2013; 7(26):2952. [In Persian] http://etiadpajohi.ir/article-1-286-en.html.

  • 4.

    Sadeghian E, Afshar Moghadam F. Determination of factors affecting the medication compliance in patients admitted to psychiatric wards. J Qazvin Univ Med Sci. 2005; 9(3):26-33. [In Persian] http://journal.qums.ac.ir/article-1-721-en.html.

  • 5.

    Neathery M. Treatment and spiritual care in mental health: Recovery as a journey, not a Destination. J Christ Nurs. 2018; 35(2):86-92. [DOI:10.1097/CNJ.0000000000000475] [PMID].

  • 6.

    Sadock BJ, Sadock VA, Kaplan HI. Kaplan and Sadocks concise textbook of child and adolescent psychiatry. Philadelphia: Lippincott Williams & Wilkins; 2009. https://books.google.com/ books?id=DUFZ9NP2GK0C&dq.

  • 7.

    Charpentier A, Goudemand M, Thomas P. Therapeutic alliance, a stake in Schizophrenia. Encephale. 2009; 35(1):80-9. [In French] [DOI:10.1016/j.encep.2007.12.009] [PMID].

  • 8.

    Ebrahimi H, Ranjbar F, Namdar H, Mosaffa F. The effect of therapeutic relationship in schizophrenic patients. J Urmia Nurs Midwifery Fac. 2014; 12(6):491-8. [In Persian] http://unmf. umsu.ac.ir/article-1-1636-en.html.

  • 9.

    Arnow BA, Steidtmann D, Blasey C, Manber R, Constantino MJ, Klein DN, et al. The relationship between the therapeutic alliance and treatment outcome in two distinct psychotherapies for chronic depression. J Consult Clin Psychol. 2013; 81(4):62738. [DOI:10.1037/a0031530] [PMID] [PMCID].

  • 10.

    Morrison M, Valfre MM. Foundations of mental health nursing. Maryland Heights: Mosby; 1997 https://books.google. com/books?id=V7NrAAAAMAAJ&q.

  • 11.

    Steger KA, Cassidy C, Rabinovitch M, Joober R, Malla A. Impact of symptom resolution on medication adherence in first episode psychosis. Psychiatry Res. 2012; 196(1):45-51. [DOI:10.1016/j.psychres.2011.10.015] [PMID].

  • 12.

    Minaiyan M, Taheri M, Mirmoghtadaee P, Marasi M. Comparative role of demographic factors and patients belief about prescribed medicine on adherence to drug treatment in chronic diseases. J Isfahan Med Sch. 2011; 29(156):1303-11. https://www.sid.ir/fa/journal/ViewPaper.aspx?ID=148351.

  • 13.

    Yadollahi S, Ashktorab T, Zayeri F. Medication adherence and related factors in patients with epilepsy. Hayat. 2015; 21(2):6780. [In Persian] http://hayat.tums.ac.ir/article-1-1135-en.html.

  • 14.

    Horne R, Weinman J. Patients beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999; 47(6):555-67. [DOI:10.1016/S0022-3999(99)00057-4] [PMID].

  • 15.

    Schoenthaler A, Chaplin WF, Allegrante JP, Fernandez S, Diaz-Gloster M, Tobin JN, et al. Provider communication effects medication adherence in hypertensive African Americans. Patient Educ Couns. 2009; 75(2):185-91. [DOI:10.1016/j. pec.2008.09.018] [PMID] [PMCID].

  • 16.

    Chaturvedi A, Singh y, Kalra J, Bhandari V, Dhashena DC, Ahmad S, et al. Do all non-responders to anti-hypertensive medication need a change in medication regimen? Journal, Indian Academy of Clinical Medicine. 2009; 10(1-2):32-5. https:// www.researchgate.net/profile/Yogendra_Singh35/publication/265563018.

  • 17.

    Ferrari CMM, de Sousa RMC, Castro LHM. Factors associated with treatment non-adherence in patients with epilepsy in Brazil. Seizure. 2013; 22(5):384-9. [DOI:10.1016/j.seii zure.2013.02.006] [PMID].

  • 18.

    Ettinger AB, Good MB, Manjunath R, Faught RE, Bancroft T. The relationship of depression to antiepileptic drug adherence and quality of life in epilepsy. Epilepsy Behav. 2014; 36:138-43. [DOI:10.1016/j.yebeh.2014.05.011] [PMID].

  • 19.

    Hunt R. Introduction to community-based nursing. Philadelphia: Lippincott Williams & Wilkins; 2009. https://books. google.com/books?id=LRu9WC-5vysC&dq.

  • 20.

    Reiter JT, Dobmeyer AC, Hunter CL. The Primary Care Behavioral Health (PCBH) model: An overview and operational definition. J Clin Psychol Med Settings. 2018; 25(2):109-26. [DOI:10.1007/s10880-017-9531-x] [PMID].

  • 21.

    Gordon E, Kenny M. Group work in psychiatric/mental health nursing: The case for psychoeducation as a means to therapeutic ends. In: Santos JC, Cutcliffe JR, editors. European Psychiatric/Mental Health Nursing in the 21st Century. Cham; Springer: 2018. pp. 269-82. https://books.google.com/ books?id=Ph5KDwAAQBAJ&dq.

  • 22.

    Namdar H, Ebrahimi H, Yazdani M, Safaeian A. Non-compliance with medication regimens in patients with Schizophrenia. Iran J Psychiatry Clin Psychol. 2006; 11(4):463-66. [In Persian] http://ijpcp.iums.ac.ir/article-1-53-en.html.

  • 23.

    Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008; 10(5):348-54. [DOI:10.1111/j.1751-7176.2008.07572.x] [PMID].

  • 24.

    Ghanei Gheshlagh R, Ebadi A, Veisi Raygani AA, Nourozi Tabrizi K, Dalvandi A, Mahmoodi H. Determining concurrent validity of the morisky medication adherence scale in patients with type 2 diabetes. Iran J Rehab Res Nurs. 2015; 1(3):24-32. [In Persian] http://ijrn.ir/article-1-98-en.html.

  • 25.

    Staring ABP, Van der Gaag M, Koopmans GT, Selten JP, Van Beveren JM, Hengeveld MW, et al. Treatment adherence therapy in people with psychotic disorders: Randomised controlled trial. Br J Psychiatry. 2010; 197(6):448-55. [DOI:10.1192/bjp. bp.110.077289] [PMID].

  • 26.

    Sweileh WM, Zyoud SH, Abu Naba RJ, Deleq MI, Enaia MI, Nassar SM, et al. Influence of patients disease knowledge and beliefs about medicines on medication adherence: Findings from a cross-sectional survey among patients with type 2 diabetes mellitus in Palestine. BMC Public Health. 2014; 14:94. [DOI:10.1186/1471-2458-14-94] [PMID] [PMCID].

  • 27.

    Mashrouteh M, Khanjani N, Gozashti MH. Evaluation of compliance with drug regimens in diabetic patients referred to the endocrinology clinic of Afzalipour Hospital, Kerman, Iran. Health Dev J. 2012; 1(3):182-92. [In Persian] http:// jhad.kmu.ac.ir/article-1-12-en.html.

  • 28.

    Tang F, Zhu G, Jiao Z, Ma C, Wang B. Self-reported adherence in patients with epilepsy who missed their medications and reasons for nonadherence in China. Epilepsy Behav. 2013; 27(1):85-9. [DOI:10.1016/j.yebeh.2012.12.022] [PMID].

  • 29.

    Hovinga CA, Asato MR, Manjunath R, Wheless JW, Phelps SJ, Sheth RD, et al. Association of non-adherence to antiepileptic drugs and seizures, quality of life, and productivity: Survey of patients with epilepsy and physicians. Epilepsy Behav. 2008; 13(2):316-22. [DOI:10.1016/j.yebeh.2008.03.009] [PMID].

  • 30.

    Getachew H, Dekema NH, Awol SS , Abdi AA , Mohammed MA. Medication adherence in epilepsy and potential risk factors associated with non adherence in tertiary care teaching hospital in southwest Ethiopia. Gaziantep Med J. 2014; 20(1):59-65. [DOI:10.5455/GMJ-30-45904].

  • 31.

    Johnbull OS, Farounbi B, Adeleye AO, Ogunrin O, Uche AP. Evaluation of factors influencing medication adherence in patients with epilepsy in rural communities of Kaduna State, Nigeria. Neurosci Med. 2011; 2(04):299-305. [DOI:10.4236/nm.2011.24039.

  • 32.

    Gabr WM, Shams MEE. Adherence to medication among outpatient adolescents with epilepsy. Saudi Pharm J. 2015; 23(1):33-40. [DOI:10.1016/j.jsps.2014.05.003] [PMID] [PMCID].

  • 33.

    Liu J, Liu z, Ding H, Yang X. Adherence to treatment and influencing factors in a sample of Chinese epilepsy patients. Epileptic Disord. 2013; 15(3):289-94. [DOI:10.1684/epd.2013.0588] [PMID]##.